Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors led by Christopher Viehbacher, former chief executive of Sanofi, has launched Boston Pharmaceuticals, a fully-integrated drug development company that says it will offer an alternative model for drug development and commercialization. Boston Pharmaceuticals will partner with academic, biotechnology and biopharmaceutical groups to acquire clinical assets at various stages of their development. The comp...